{"version":"1.0","provider_name":"Agenzia di Comunicazione e Marketing Integrato","provider_url":"https:\/\/www.mapcommunication.it\/en\/","author_name":"MAP Communication","author_url":"https:\/\/www.mapcommunication.it\/en\/author\/dev_m4pc0mmun1c4t10n\/","title":"CYSTIC FIBROSIS: A MAJOR STEP FORWARD FOR PATIENTS","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"zkBZTZ48XN\"><a href=\"https:\/\/www.mapcommunication.it\/en\/news\/cystic-fibrosis-a-major-step-forward-for-patients\/\">CYSTIC FIBROSIS: A MAJOR STEP FORWARD FOR PATIENTS<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/www.mapcommunication.it\/en\/news\/cystic-fibrosis-a-major-step-forward-for-patients\/embed\/#?secret=zkBZTZ48XN\" width=\"600\" height=\"338\" title=\"&#8220;CYSTIC FIBROSIS: A MAJOR STEP FORWARD FOR PATIENTS&#8221; &#8212; Agenzia di Comunicazione e Marketing Integrato\" data-secret=\"zkBZTZ48XN\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/www.mapcommunication.it\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/www.mapcommunication.it\/wp-content\/uploads\/2025\/11\/fibrosi-cistica_map_news_EMA_CHMP_farmaci-821x1024-1.jpg","thumbnail_width":821,"thumbnail_height":1024,"description":"CHMP favourable opinion to extend the therapeutic indication of the two medicinal products Kaftrio and Kalydeco Very important news has come from the Committee for Medicinal Products for Human Use (CHMP) of the EMA (European Medicines Agency) for the future of many people affected by Cystic Fibrosis: the agency has in fact recommended extending the [&hellip;]"}